Science

2019

Management of bone health in solid tumours: From bisphosphonates to a monoclonal antibody

Von Moos R, Costa L, Gonzalez-Suarez E, Terpos E, Niepel D, Body JJ

Journal: Cancer Treatment Reviews
Volume: 76
Année: Juin 2019
Pages: 57-67

https://doi.org/10.1016/j.ctrv.2019.05.003

Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice

Marino S, de Ridder D, Bishop RT, Renema N, Ponzetti M, Sophocleous A, Capulli M, Aljeffery A, Carrasco G, Gens MD, Khogeer A, Ralston SH, Gertsch J, Lamoureux F, Heymann D, Rucci N, Idris AI

Journal: EBioMedicine
Volume: 44
Année: Juin 2019
Pages: 452-466

https://doi.org/10.1016/j.ebiom.2019.05.048

Bone health in childhood cancer: review of the literature and recommendations for the management of bone health in childhood cancer survivors

Marcucci G, Beltrami G, Tamburini A, Body JJ, Confavreux CB, Hadji P, Holzer G, Kendler D, Napoli N, Pierroz DD, Rizzoli R, Brandi ML

Journal: Annals of Oncology
Volume: 30, Issue 6
Année: Juin 2019
Pages: 908-920

https://doi.org/10.1093/annonc/mdz120

Radionuclide imaging and therapy of bone metastases in the era of targeted therapy

Van den Wyngaert T, Paycha F

Journal: Journal of Nuclear Medicine and Molecular Imaging
Volume: 63, Issue 2
Année: Juin 2019
Pages: 95

https://doi.org/10.23736/S1824-4785.19.03207-2

Comparison of bone lesion distribution between prostate cancer and multiple myeloma with whole-body MRI

Larbi A, Omoumi P, Pasoglou V, Michoux N, Triqueneaux P, Tombal B, Cyteval C, Lecouvet FE

Journal: Diagnostic and Interventional Imaging
Volume: 100, Issue 5
Année: Mai 2019
Pages: 295-302

https://doi.org/10.1016/j.diii.2018.12.005

Bone metastases from lung cancer: A paradigm for multidisciplinary onco-rheumatology management

Confavreux CB, Pialat JB, Bellière A, Brevet M, Decroisette C, Tescaru A, Wegrzyn J, Barrey C, Mornex F, Souquet PJ, Girard N

Journal: Joint Bone Spine
Volume: 86, Issue 2
Année: Mars 2019
Pages: 185-194

https://doi.org/10.1016/j.jbspin.2018.03.005

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe

Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F, Hechmati G, Qian Y

Journal: Journal of Bone Oncology
Volume: 14
Année: Février 2019
Pages:100212

https://doi.org/10.1016/j.jbo.2018.100212

French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation

Briot K, Paccou J, Beuzeboc P, Bonneterre J, Bouvard B, Confavreux CB, Cormier C, Cortet B, Hannoun-Lévi JM, Hennequin C, Javier RM, Lespessailles E, Mayeur D, Mongiat Artus P, Vieillard MH, Debiais F

Journal: Joint Bone Spine
Volume: 86, Issue 1
Année: Janvier 2019
Pages: 21-28

https://doi.org/10.1016/j.jbspin.2018.09.017

2018

TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases

Delliaux C, Tian TV, Bouchet M, Fradet A, Vanpouille N, Florens A, Deplus R, Villers A, Leroy X, Clézardin P, De Launoit Y, Bonnelye E, Duterque-Coquillaud M

Journal: Cancer Letters
Volume: 438
Année: Décembre 2018
Pages: 32-43

https://doi.org/10.1016/j.canlet.2018.08.027